Thymoma laboratory tests: Difference between revisions
Jump to navigation
Jump to search
| Line 23: | Line 23: | ||
*[[Antibodies]] to the [[acetylcholine receptor]] (indicative of [[myasthenia gravis]]) | *[[Antibodies]] to the [[acetylcholine receptor]] (indicative of [[myasthenia gravis]]) | ||
*[[Liver enzyme]]s derangement | *[[Liver enzyme]]s derangement | ||
*Hypoalbuminemia<ref>{{Cite journal | *[[Hypoalbuminemia]]<ref>{{Cite journal | ||
| author = [[Shin Hye Yoo]], [[Hyean-Ji Kim]], [[Jeong-Han Kim]], [[Gyeong-Won Lee]], [[Jeong Hee Lee]], [[Se Hyun Kim]], [[Ji-Won Kim]], [[Jin Won Kim]], [[Jeong-Ok Lee]], [[Yu Jung Kim]], [[Keun-Wook Lee]], [[Jee Hyun Kim]], [[Soo-Mee Bang]] & [[Jong Seok Lee]] | | author = [[Shin Hye Yoo]], [[Hyean-Ji Kim]], [[Jeong-Han Kim]], [[Gyeong-Won Lee]], [[Jeong Hee Lee]], [[Se Hyun Kim]], [[Ji-Won Kim]], [[Jin Won Kim]], [[Jeong-Ok Lee]], [[Yu Jung Kim]], [[Keun-Wook Lee]], [[Jee Hyun Kim]], [[Soo-Mee Bang]] & [[Jong Seok Lee]] | ||
| title = Nephrotic syndrome associated with metastatic thymoma treated with chemotherapy | | title = Nephrotic syndrome associated with metastatic thymoma treated with chemotherapy | ||
| Line 35: | Line 35: | ||
| pmid = 28072685 | | pmid = 28072685 | ||
}}</ref> | }}</ref> | ||
*Proteinuria<ref>{{Cite journal | *[[Proteinuria]]<ref>{{Cite journal | ||
| author = [[Shin Hye Yoo]], [[Hyean-Ji Kim]], [[Jeong-Han Kim]], [[Gyeong-Won Lee]], [[Jeong Hee Lee]], [[Se Hyun Kim]], [[Ji-Won Kim]], [[Jin Won Kim]], [[Jeong-Ok Lee]], [[Yu Jung Kim]], [[Keun-Wook Lee]], [[Jee Hyun Kim]], [[Soo-Mee Bang]] & [[Jong Seok Lee]] | | author = [[Shin Hye Yoo]], [[Hyean-Ji Kim]], [[Jeong-Han Kim]], [[Gyeong-Won Lee]], [[Jeong Hee Lee]], [[Se Hyun Kim]], [[Ji-Won Kim]], [[Jin Won Kim]], [[Jeong-Ok Lee]], [[Yu Jung Kim]], [[Keun-Wook Lee]], [[Jee Hyun Kim]], [[Soo-Mee Bang]] & [[Jong Seok Lee]] | ||
| title = Nephrotic syndrome associated with metastatic thymoma treated with chemotherapy | | title = Nephrotic syndrome associated with metastatic thymoma treated with chemotherapy | ||
| Line 47: | Line 47: | ||
| pmid = 28072685 | | pmid = 28072685 | ||
}}</ref> | }}</ref> | ||
*Hyponatremia | *[[Hyponatremia]] | ||
*Hypercholesterolemia | *[[Hypercholesterolemia]] | ||
*[[ANA|Antineutrophil antibody]] | *[[ANA|Antineutrophil antibody]] | ||
*Anti-nuclear antibody (indicative of autoimmune hepatitis)<ref>{{Cite journal | *[[Anti-nuclear antibody]] (indicative of [[autoimmune hepatitis]])<ref>{{Cite journal | ||
| author = [[Tomoki Nishimura]], [[Hiroaki Tsunezuka]], [[Naoko Miyata]] & [[Masayoshi Inoue]] | | author = [[Tomoki Nishimura]], [[Hiroaki Tsunezuka]], [[Naoko Miyata]] & [[Masayoshi Inoue]] | ||
| title = Autoimmune hepatitis during preoperative chemotherapy in a patient with thymoma | | title = Autoimmune hepatitis during preoperative chemotherapy in a patient with thymoma | ||
Latest revision as of 14:23, 15 August 2019
|
Thymoma Microchapters |
|
Diagnosis |
|---|
|
Case Studies |
|
Thymoma laboratory tests On the Web |
|
American Roentgen Ray Society Images of Thymoma laboratory tests |
|
Risk calculators and risk factors for Thymoma laboratory tests |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amr Marawan, M.D. [2] Ahmad Al Maradni, M.D. [3]
Overview
Laboratory findings associated with thymoma may include antibodies against the acetylcholine receptor, abnormal electrolytes, renal, and liver function tests.
Laboratory Findings
Patients with thymoma can have the following laboratory findings:[1]
- Pure red cell aplasia on bone marrow biopsy
- Hypogammaglobulinemia on protein electrophoresis[2]
- Antibodies to the acetylcholine receptor (indicative of myasthenia gravis)
- Liver enzymes derangement
- Hypoalbuminemia[3]
- Proteinuria[4]
- Hyponatremia
- Hypercholesterolemia
- Antineutrophil antibody
- Anti-nuclear antibody (indicative of autoimmune hepatitis)[5]
References
- ↑ Thomas CR, Wright CD, Loehrer PJ (1999). "Thymoma: state of the art". Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 17 (7): 2280–9. PMID 10561285. Retrieved 2012-01-18. Unknown parameter
|month=ignored (help) - ↑ Y. Jamilloux, H. Frih, C. Bernard, C. Broussolle, P. Petiot, N. Girard & P. Seve (2018). "[Thymoma and autoimmune diseases]". La Revue de medecine interne. 39 (1): 17–26. doi:10.1016/j.revmed.2017.03.003. PMID 28365191. Unknown parameter
|month=ignored (help) - ↑ Shin Hye Yoo, Hyean-Ji Kim, Jeong-Han Kim, Gyeong-Won Lee, Jeong Hee Lee, Se Hyun Kim, Ji-Won Kim, Jin Won Kim, Jeong-Ok Lee, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang & Jong Seok Lee (2017). "Nephrotic syndrome associated with metastatic thymoma treated with chemotherapy". Medicine. 96 (1): e5408. doi:10.1097/MD.0000000000005408. PMID 28072685. Unknown parameter
|month=ignored (help) - ↑ Shin Hye Yoo, Hyean-Ji Kim, Jeong-Han Kim, Gyeong-Won Lee, Jeong Hee Lee, Se Hyun Kim, Ji-Won Kim, Jin Won Kim, Jeong-Ok Lee, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang & Jong Seok Lee (2017). "Nephrotic syndrome associated with metastatic thymoma treated with chemotherapy". Medicine. 96 (1): e5408. doi:10.1097/MD.0000000000005408. PMID 28072685. Unknown parameter
|month=ignored (help) - ↑ Tomoki Nishimura, Hiroaki Tsunezuka, Naoko Miyata & Masayoshi Inoue (2019). "Autoimmune hepatitis during preoperative chemotherapy in a patient with thymoma". Interactive cardiovascular and thoracic surgery. doi:10.1093/icvts/ivz138. PMID 31177282. Unknown parameter
|month=ignored (help)